News | April 15, 2025
Biocon Biologics secures market entry date for Yesafili in US
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
The product will be launched in Q1FY26
_256_384.jpg)
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
The company expects to launch this product through its marketing partner in the near future
Subscribe To Our Newsletter & Stay Updated
